BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4960899)

  • 1. In vitro and in vivo characterization of pyocin.
    Higerd TB; Baechler CA; Berk RS
    J Bacteriol; 1967 Jun; 93(6):1976-86. PubMed ID: 4960899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological studies on relaxed and contracted forms of purified pyocin particles.
    Higerd TB; Baechler CA; Berk RS
    J Bacteriol; 1969 Jun; 98(3):1378-89. PubMed ID: 4977989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, homogeneity, and properties of core particle from pyocin R1.
    Hasegawa T; Ishii S
    J Biochem; 1979 Feb; 85(2):403-11. PubMed ID: 106048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A circular dichroism study of sheath contraction in pyocin R1.
    Uratani Y
    Biochim Biophys Acta; 1982 May; 703(2):196-203. PubMed ID: 6805516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R-type pyocin of Pseudomonas aeruginosa C is a bacteriophage tail-like particle that contains single-stranded DNA.
    Lee FK; Dudas KC; Hanson JA; Nelson MB; LoVerde PT; Apicella MA
    Infect Immun; 1999 Feb; 67(2):717-25. PubMed ID: 9916082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit arrangement in the extended sheath of pyocin R.
    Takeda Y; Kageyama M
    J Biochem; 1975 Mar; 77(3):679-84. PubMed ID: 807567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of pyocin R1 fibers.
    Kumazaki T; Ogura Y; Ishii S
    J Biochem; 1982 Mar; 91(3):825-35. PubMed ID: 6804455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, purification and characterization of a pyocin.
    Faydi YR; Nabbut NH
    Ann Microbiol (Paris); 1978 Apr; 129(3):313-22. PubMed ID: 96719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective pyocin particles produced by some mutant strains of Pseudomonas aeruginosa.
    Shinomiya T; Osumi M; Kageyama M
    J Bacteriol; 1975 Dec; 124(3):1508-21. PubMed ID: 811648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein makeup of the sheath of pyocin R1].
    Turkin AI; Metlina AL; Poglazov BF
    Dokl Akad Nauk SSSR; 1978; 239(3):740-2. PubMed ID: 417910
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfhydryl groups of pyocin R1. Morphology and activity modified with sulfhydryl reagents.
    Hasegawa T; Terayama K; Azegami M; Ishii S
    J Biochem; 1979 Apr; 85(4):977-88. PubMed ID: 110797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characteristics of pyocin B39 II. Physical and chemical properties.
    Chen C; Tai F
    Antimicrob Agents Chemother; 1972 Feb; 1(2):159-63. PubMed ID: 4218942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of an S-type pyocin, pyocin AP41.
    Sano Y; Kageyama M
    J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on biosynthesis and morphogenesis of R-type pyocins of Pseudomonas aeruginosa. II. Biosynthesis of antigenic proteins and their assembly into pyocin particles in mitomycin C-induced cells.
    Shinomiya T
    J Biochem; 1972 Jul; 72(1):39-48. PubMed ID: 4627056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.